Condition: Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Carcinoma · Sponsor: Shanghai Gynecologic Oncology Group
Optimal Timing of Surgery combined with Maintenance Therapy in the Front-line Treatment of Advanced Ovarian Cancer
This description comes directly from the study's public registry record.
Libing Xiang · 86 21 64041990 · xiang.libing@zs-hospital.sh.cn
Rong Jiang · 86 21 64041990 · jiang.rong@zs-hospital.sh.cn
Always discuss trial participation with your own doctor first.
| The First People's Hospital of Foshan | Foshan, China | Recruiting |
| Sun Yet-Sen University Cancer Center | Guangzhou, China | Recruiting |
| The First Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou, China | Recruiting |
| Zhejiang Cancer Hospital | Hangzhou, China | Recruiting |
| The First Affiliated Hospital of University of Science and Technology of China | Hefei, China | Recruiting |
| Fudan University Cancer Hospital | Shanghai, China | Recruiting |
| Obstetrics and Gynecology Hospital of Fundan University | Shanghai, China | Recruiting |
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai, China | Recruiting |
| Zhongshan Hospital, Fudan University | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05200260